CHANTIX is a Kit in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is .
| Product ID | 0069-0471_1ec8e989-320f-438d-882c-201b0fe6b23f | 
| NDC | 0069-0471 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | CHANTIX | 
| Generic Name | Varenicline Tartrate | 
| Dosage Form | Kit | 
| Marketing Start Date | 2006-05-10 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA021928 | 
| Labeler Name | Pfizer Laboratories Div Pfizer Inc | 
| Active Ingredient Strength | 0 | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2006-05-10 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA021928 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2006-05-10 | 
| Marketing Category | NDA | 
| Application Number | NDA021928 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2006-05-10 | 
| Marketing End Date | 2015-02-03 | 
| Marketing Category | NDA | 
| Application Number | NDA021928 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2006-05-10 | 
| Marketing End Date | 2017-11-30 | 
| Marketing Category | NDA | 
| Application Number | NDA021928 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2006-05-10 | 
| Marketing End Date | 2017-11-30 | 
| SPL SET ID: | f0ff4f27-5185-4881-a749-c6b7a0ca5696 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0069-0468 | CHANTIX | varenicline tartrate | 
| 0069-0469 | CHANTIX | varenicline tartrate | 
| 0069-0471 | CHANTIX | varenicline tartrate | 
| 21695-633 | Chantix | varenicline tartrate | 
| 21695-945 | CHANTIX | varenicline tartrate | 
| 21695-946 | Chantix | varenicline tartrate | 
| 43353-899 | CHANTIX | varenicline tartrate | 
| 50090-0995 | CHANTIX | varenicline tartrate | 
| 50090-0998 | CHANTIX | varenicline tartrate | 
| 50090-3528 | CHANTIX | varenicline tartrate | 
| 50090-4481 | CHANTIX | varenicline tartrate | 
| 50090-4482 | CHANTIX | varenicline tartrate | 
| 63187-618 | CHANTIX | varenicline tartrate | 
| 63539-473 | CHANTIX | varenicline tartrate | 
| 68151-4953 | CHANTIX | CHANTIX | 
| 68151-4952 | CHANTIX | CHANTIX | 
| 69189-0492 | CHANTIX | CHANTIX | 
| 71205-381 | CHANTIX | CHANTIX | 
| 49884-155 | Varenicline | varenicline tartrate | 
| 49884-156 | Varenicline | varenicline tartrate | 
| 49884-944 | Varenicline | varenicline tartrate | 
| 60687-648 | Varenicline | varenicline tartrate | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  CHANTIX  88847451  not registered Live/Pending | Pfizer Inc. 2020-03-25 | 
|  CHANTIX  88847449  not registered Live/Pending | Pfizer Inc. 2020-03-25 | 
|  CHANTIX  78893080  3407173 Live/Registered | Pfizer Inc. 2006-05-25 | 
|  CHANTIX  78875811  not registered Dead/Abandoned | Pfizer Inc. 2006-05-03 | 
|  CHANTIX  78835879  3321317 Live/Registered | Pfizer Inc. 2006-03-13 |